Legal Opinion
In Re Gilead Sciences Securities Litigation
Court of Appeals for the Ninth Circuit
Decided August 11, 2008No. 06-16185PublishedCited by 1,474 opinions
1Opinion of the Court
MICHAEL DALY HAWKINS, Circuit Judge:
A group of individual investors brought this securities fraud action on behalf of themselves and a proposed class comprising all individuals (collectively, the “Investors”) who purchased Gilead Sciences, Inc.’s (“Gilead”) publicly traded securities between July 14, 2003, and October 28, 2003 (“class period”). They allege that Gilead misled the investing public by representing that demand for its most popular product was strong without disclosing that unlawful marketing was the cause of that strength.
The district court dismissed under Rule 12(b)(6) of Civil…
2Cases cited14 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Sprewell v. Golden State WarriorsCourt of Appeals for the Ninth Circuit · 2001
- Dura Pharmaceuticals, Inc. v. BroudoSupreme Court of the United States · 2005
- Buckman Co. v. Plaintiffs' Legal CommitteeSupreme Court of the United States · 2001
- Sprewell v. Golden State WarriorsCourt of Appeals for the Ninth Circuit · 2001
9 more not listed; retrieve them via the Exa API.
3Cited by1,474 opinions
- Karim Khoja v. Orexigen Therapeutics, Inc.Court of Appeals for the Ninth Circuit · 2018
- Lormand v. US Unwired, Inc.Court of Appeals for the Fifth Circuit · 2009
- In Re Oracle Corp. Securities LitigationCourt of Appeals for the Ninth Circuit · 2010
- Reese v. BP Exploration (Alaska) Inc.Court of Appeals for the Ninth Circuit · 2011
- Cutera Securities Litigation v. ConnersCourt of Appeals for the Ninth Circuit · 2010
1,469 more not listed; retrieve them via the Exa API.